Arthritis Research UK
Copeman House St Marys Gate,
Chesterfield, S41 7TD,
United Kingdom
Chesterfield, S41 7TD,
United Kingdom
44 300 790 0400
Non Profit
Arthritis Research UK Technographics
Arthritis Research UK Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Arthritis Research UK and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 166 Arthritis Research UK employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Arthritis Research UK has purchased the following applications: IBM Watson Assistant for Chatbots and Conversational AI in 2016, Microsoft 365 for Collaboration in 2017, Exclaimer Cloud Signatures for Office 365 for Digital Signing in 2017 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Arthritis Research UK is running and its propensity to invest more and deepen its relationship with IBM , Microsoft , Exclaimer or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Arthritis Research UK revenues, which have grown to $15.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Arthritis Research UK intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Arthritis Research UK Tech Stack and Enterprise Applications
AI-Powered Application
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| IBM | Legacy | IBM Watson Assistant | Chatbots and Conversational AI | AI-Powered Application | x | 2016 | 2017 |
In 2016, Arthritis Research UK implemented IBM Watson Assistant as a virtual assistant built on the IBM Cloud platform. The deployment positioned IBM Watson Assistant within the Chatbots and Conversational AI category to provide automated answers for a broad range of self management topics relevant to patients and the public.
The implementation configured conversational flows, intent classification, entity extraction, and content mapping to structure responses across topic areas. IBM Watson Assistant hosted dialog logic and natural language understanding capabilities, with training driven by Arthritis Research UK content to tune intents and response variance.
The solution was deployed as a cloud hosted service on the IBM Cloud platform, centralizing conversational logic and content management. Operational coverage focused on customer facing information services at Arthritis Research UK, with governance practices emphasizing editorial control of knowledge content and iterative intent training to maintain response accuracy.
|
Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2017 | 2017 |
In 2017, Arthritis Research UK implemented Microsoft 365 to consolidate Collaboration capabilities across the organization. Microsoft 365 was provisioned to support core collaboration workflows for research, fundraising and administrative teams, and to provide a single cloud tenant for email, document collaboration and team communication.
The Microsoft 365 deployment emphasized cloud email, document storage and co-authoring, calendaring and real-time messaging as primary functional modules. Microsoft 365 was used to surface content on the public website, indicating the tenant is active for web-facing content management or embedded collaboration functionality.
Operational coverage spanned internal departments responsible for research coordination, donor engagement and back-office operations, with governance centered on centralized tenant administration, role-based access controls and document sharing policies. The implementation aligns Arthritis Research UK Microsoft 365 Collaboration with standard collaboration controls and workflows to support cross-functional communication and document lifecycle management.
|
Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Exclaimer | Legacy | Exclaimer Cloud Signatures for Office 365 | Digital Signing | Content Management | n/a | 2017 | 2017 |
In 2017, Arthritis Research UK implemented Exclaimer Cloud Signatures for Office 365 as a Digital Signing solution to centralize email signature management for corporate communications and fundraising. The presence of Exclaimer Cloud Signatures for Office 365 assets on the Arthritis Research UK website corroborates a cloud hosted signature provisioning model tied to the organisation's Office 365 tenant. This deployment is consistent with a small non profit environment based in the United Kingdom with a single centralized tenancy.
Configuration and functional scope focused on centralized signature template management, server side signature insertion into outbound mail flow, and rule based signature application by user role and department. Typical Digital Signing capabilities implemented include templated signature blocks, marketing banner placement and legal footer standardization, plus dynamic population of user attributes from the Office 365 directory to maintain brand consistency across email channels. The implementation emphasizes template version control and policy driven application of signatures to ensure uniformity across fundraising, marketing and donor communications.
Operationally the solution integrates with the organisation's Office 365 mail flow and directory attributes to automate signature assignment across staff email accounts. Governance appears to be centralized, with administrative controls for signature templates and rule sets likely held by IT or corporate communications to enforce brand and regulatory requirements. Exclaimer Cloud Signatures for Office 365, as deployed by Arthritis Research UK, serves the business function of centralized email signature management under the Digital Signing category, covering organization wide corporate messaging and external donor engagement.
|
CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Customer Support | CRM |
|
2014 | 2014 |
|
IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2020 | 2020 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2021 | 2021 |
|
IT Decision Makers and Key Stakeholders at Arthritis Research UK
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Arthritis Research UK Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Arthritis Research UK IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Arthritis Research UK digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Arthritis Research UK Technographics
Arthritis Research UK is a Non Profit organization based in United Kingdom,
with around 166 employees and annual revenues of $15.0 million.
Arthritis Research UK operates a diverse technology stack with applications such as
IBM Watson Assistant, Microsoft 365 and Exclaimer Cloud Signatures for Office 365,
covering areas like Chatbots and Conversational AI, Collaboration and Digital Signing.
Arthritis Research UK has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as IBM, Microsoft and Exclaimer.
Arthritis Research UK recently adopted applications including
GoDaddy in 2021, Microsoft Azure Cloud Services in 2020 and Microsoft 365 in 2017,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Arthritis Research UK’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Arthritis Research UK’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Arthritis Research UK technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.